Joseph K. Belanoff. - 27 Feb 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Chief Executive Officer, Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff.
Issuer symbol
CORT
Transactions as of
27 Feb 2026
Net transactions value
$0
Form type
4
Filing time
03 Mar 2026, 18:17:15 UTC
Previous filing
29 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
BELANOFF JOSEPH K Chief Executive Officer, Director C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for Joseph K. Belanoff. 03 Mar 2026 0001286199

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock Option (right to buy) Award $0 +460,000 $0.000000 460,000 27 Feb 2026 Common Stock 460,000 $35.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise ratably in equal installments on each monthly anniversary of February 27, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.